SCHEDULE 13G/A: BlackRock Amends Passive Stake in Elanco Animal Health, Disclosing 4.4% Ownership
Beneficial Ownership Disclosure
BlackRock, Inc. has filed an amendment to its Schedule 13G, reporting a 4.4% passive beneficial ownership stake in Elanco Animal Health Inc. as of March 31, 2025.
Summary
- BlackRock, Inc. filed an Amendment No. 1 to its Schedule 13G regarding its beneficial ownership in Elanco Animal Health Inc.
- As of March 31, 2025, BlackRock beneficially owns an aggregate of 22,023,648 shares of Elanco Animal Health Inc. Common Stock.
- This beneficial ownership represents 4.4% of the total outstanding class of securities.
- BlackRock holds sole voting power over 20,738,250 shares and sole dispositive power over 22,023,648 shares.
- The filing certifies that BlackRock holds these securities in the ordinary course of business and not for the purpose of changing or influencing control of Elanco Animal Health Inc.
Sentiment
Score: 5
Explanation: The document is a factual, routine regulatory filing (Schedule 13G) disclosing passive beneficial ownership. It contains no positive or negative operational or financial news about the issuer, Elanco Animal Health Inc. The sentiment is neutral as it simply reports an institutional investor's stake below the 5% threshold for active reporting.
Future Outlook
NA
Management Comments
- "After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct." Spencer Fleming, Managing Director, BlackRock, Inc.
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Update (BlackRock, Inc.) | BlackRock, Inc. updated its Power of Attorney, effective January 21, 2025, revoking a previous one dated April 30, 2023. This document authorizes specific individuals to execute and file SEC documents on behalf of BlackRock and its subsidiaries. | 2025-01-21 | Streamlines BlackRock's internal process for regulatory filings, ensuring compliance with ownership reporting requirements. |
Stakeholder Impact
- Shareholders of Elanco Animal Health Inc.: Provides transparency regarding a significant institutional investor's passive stake, confirming BlackRock's position below the 5% threshold for active reporting.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Date of the previous Power of Attorney, which was revoked. |
| 2025-01-21 | Effective date of the new Power of Attorney for BlackRock, Inc. |
| 2025-03-31 | Date of event which requires the filing of this statement, reflecting BlackRock's beneficial ownership. |
| 2025-04-22 | Date of filing of the Schedule 13G Amendment No. 1. |
Recommendation
holdKeywords
Elanco Animal Health Inc, BlackRock, Schedule 13G, beneficial ownership, common stock, passive investment, institutional investor, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.